Atlas Trials

Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE)

Clinical trial NCT02151539 · TERMINATED

Trial details

NCT number
NCT02151539
Sponsor
Vanderbilt-Ingram Cancer Center
Status
TERMINATED
Study type
OBSERVATIONAL
Graft Versus Host Disease
Start date
2014-08-29
Primary completion
2018-10-11
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.